Intraperitoneal Carboplatin with or without Interferon- in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients

Author： Bruzzone M.   Rubagotti A.   Gadducci A.   Catsafados E.   Foglia G.   Brunetti I.   Giannessi P.G.   Carnino F.   Iskra L.   Rosso R.   Martoni A.   Pannuti F.   De Lisi V.   Maltoni R.   Ridolfi R.   Mammoliti S.   Gallo L.   Boccardo F.   Ragni N.   Conte P.F.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.65, Iss.3, 1997-06, pp. : 499-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy-A Randomized Phase II Study by the Southwest Oncology Group

By Muggia F.M.   Liu P.Y.   Alberts D.S.   Wallace D.L.   O'Toole R.V.   Terada K.Y.   Franklin E.W.   Herrer G.W.   Goldberg D.A.   Hannigan E.V.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 395-402

Academic Press

Access to resources Recommend Favorite

Single-dose Intraperitoneal Radioimmunotherapy with the Murine Monoclonal Antibody I-131 MOv18: Clinical Results in Patients with Minimal Residual Disease of Ovarian Cancer

By Crippa F.   Bolis G.   Seregni E.   Gavoni N.   Scarfone G.   Ferraris C.   Buraggi G.L.   Bombardieri E.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 686-690

Elsevier

Access to resources Recommend Favorite

Intraperitoneal Cisplatin and Intravenous Paclitaxel in the Treatment of Epithelial Ovarian Cancer Patients with a Positive Second Look

By Makhija S.   Sabbatini P.   Aghajanian C.   Venkatraman E.   Spriggs D.R.   Barakat R.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 28-32

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer

By Husain A.   Sabbatini P.   Spriggs D.   Fennelly D.   Aghajanian C.   Barakat R.   Curtin J.   Venkatraman E.   Hoskins W.   Markman M.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 96-101

Elsevier

Access to resources Recommend Favorite

Phase II Study of Intraperitoneal Cisplatin Plus Systemic Etoposide as Second-line Treatment in Patients With Small Volume Residual Ovarian Cancer

By de Jong R.S.   Willemse P.H.B.   Boonstra H.   de Vries E.G.E.   van der Graaf W.T.A.   Sleijfer D.T.   van der Zee A.G.J.   Mulder N.H.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite